학술논문

Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study

Document Type

Article

Author

Lepage, C.; Le-Malicot, K.; Phelip, J.-M.; Lievre, A.; Dahan, L.; Tougeron, D.; Toumpanakis, C.; Di-Fiore, F.; Michel, P.; Lombard-Bohas, C.; Walter, T.; Borbath, I.; Coriat, R.; Lecomte, T.; Guimbaud, R.; Petorin, C.; Legoux, J.-L.; Scoazec, J.-Y.; Smith, D.

Source

In: European Journal of Cancer. (European Journal of Cancer, November 2022, 175:31-40)

Subject

Language

English

ISSN

18790852
09598049

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송